Literature DB >> 23110754

Endothelial function and arterial stiffness assessment as early surrogate markers of vascular risk in patients with systemic lupus erythematosus.

Calvin Woon-Loong Chin1, Ru San Tan, Julian Thumboo.   

Abstract

Patients with systemic lupus erythematosus (SLE) are at risk of premature atherosclerosis. Conventional prediction risk equations do not adequately predict the cardiovascular risk of these patients because of the complex interaction of traditional and SLE specific risk factors and treatment effects, as well as, the dynamic insult to the vasculature. Non-invasive vascular assessment is able to evaluate the vascular damage accumulated over time. The aim of this review is to examine the role of non-invasive assessment of endothelial function and arterial stiffness as surrogate markers for vascular risk in SLE patients.

Entities:  

Mesh:

Year:  2012        PMID: 23110754

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  3 in total

1.  Endothelial function is associated with myocardial diastolic function in women with systemic lupus erythematosus.

Authors:  Calvin W L Chin; Chee-Yang Chin; Marie X R Ng; Thu-Thao Le; Fei-Qiong Huang; Kok-Yong Fong; Julian Thumboo; Ru-San Tan
Journal:  Rheumatol Int       Date:  2014-02-19       Impact factor: 2.631

2.  Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus.

Authors:  Agostino Virdis; Chiara Tani; Emiliano Duranti; Sabrina Vagnani; Linda Carli; Anja A Kühl; Anna Solini; Chiara Baldini; Rosaria Talarico; Stefano Bombardieri; Stefano Taddei; Marta Mosca
Journal:  Arthritis Res Ther       Date:  2015-10-06       Impact factor: 5.156

3.  Increased arterial stiffness in systemic lupus erythematosus (SLE) patients at low risk for cardiovascular disease: a cross-sectional controlled study.

Authors:  Karim Sacre; Brigitte Escoubet; Blandine Pasquet; Marie-Paule Chauveheid; Maria-Christina Zennaro; Florence Tubach; Thomas Papo
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.